These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 13627580)

  • 1. [The effect of isoniazid and D-cycloserine on purified peroxidase and on the peroxidase activity of Mycobacterium tuberculosis].
    ANDREJEW A; GERNEZ-RIEUX C; TACQUET A
    Ann Inst Pasteur (Paris); 1959 Feb; 96(2):145-63. PubMed ID: 13627580
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bacteriostatic effect of combined cycloserine & isoniazid on Mycobacterium tuberculosis].
    VIALLIER J; CAYRE RM
    C R Seances Soc Biol Fil; 1956; 150(11):1970-1. PubMed ID: 13427287
    [No Abstract]   [Full Text] [Related]  

  • 3. Inactivation of isoniazid by peroxidase.
    TIRUNARAYANAN MO; VISCHER WA
    Nature; 1959 Mar; 183(4662):681. PubMed ID: 13632829
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro studies of the possibility of using cycloserine as a tuberculostatic in combination with intermittent therapy of tuberculosis.
    Algeorge G; Petre A
    Scand J Respir Dis Suppl; 1970; 71():35-9. PubMed ID: 4989520
    [No Abstract]   [Full Text] [Related]  

  • 5. [Appearance of non-acid fast forms of Mycobacterium tuberculosis in the presence of isoniazid, cycloserine and alpha-ethyl-thioisonicotinamide].
    DUNBAR JM
    Ann Inst Pasteur (Paris); 1957 Apr; 92(4):451-8. PubMed ID: 13425092
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibacterial activity of the optical isomers of D-, L- & DL-4-amino-3-isoxazolidinone (cycloserine); effects on Mycobacterium tuberculosis].
    SALGARELLO G; TURRI E
    Boll Soc Ital Biol Sper; 1958 Nov; 34(22):1538-40. PubMed ID: 13607852
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterisation of isoniazid-resistant Mycobacterium tuberculosis isolated from new cases in Lagunes region (Côte d'Ivoire).
    N'Guessan KR; Dosso M; Ekaza E; Kouakou J; Jarlier V
    Int J Antimicrob Agents; 2008 May; 31(5):498-500. PubMed ID: 18313272
    [No Abstract]   [Full Text] [Related]  

  • 9. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth.
    Gumbo T; Louie A; Liu W; Ambrose PG; Bhavnani SM; Brown D; Drusano GL
    J Infect Dis; 2007 Jan; 195(2):194-201. PubMed ID: 17191164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of catalase and peroxidase activity of Lowenstein cultures. Relationship between enzyme activity, isoniazid susceptibility and guinea-pig tests.
    OSCARSSON PN
    Acta Tuberc Scand; 1961; 40():51-64. PubMed ID: 13731394
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis.
    Fattorini L; Gennaro R; Zanetti M; Tan D; Brunori L; Giannoni F; Pardini M; Orefici G
    Peptides; 2004 Jul; 25(7):1075-7. PubMed ID: 15245864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of oxidative stress on the mutation rate of Mycobacterium tuberculosis with impaired catalase/peroxidase function.
    O'Sullivan DM; McHugh TD; Gillespie SH
    J Antimicrob Chemother; 2008 Oct; 62(4):709-12. PubMed ID: 18577539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
    Nusrath Unissa A; Selvakumar N; Narayanan S; Narayanan PR
    Int J Antimicrob Agents; 2008 Jan; 31(1):71-5. PubMed ID: 18006278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bactericidal activity of cycloserine on Mycobacterium tuberculosis].
    VIALLIER J; CAYRE RM
    C R Seances Soc Biol Fil; 1958; 152(4):637. PubMed ID: 13597366
    [No Abstract]   [Full Text] [Related]  

  • 15. [Research on the in vitro activity exercised by cycloserine on Mycobacterium tuberculosis].
    BRUN J; VIALLIER J; CAYRE RM
    C R Seances Soc Biol Fil; 1956; 150(8-9):1553-5. PubMed ID: 13414227
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation.
    Nikolayevsky V; Brown T; Balabanova Y; Ruddy M; Fedorin I; Drobniewski F
    J Clin Microbiol; 2004 Oct; 42(10):4498-502. PubMed ID: 15472300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cycloserine concentration in blood and urine and bacteriostatic activity on Mycobacterium tuberculosis].
    VIALLIER J; BIOT N; BOMPY S
    C R Seances Soc Biol Fil; 1957; 151(1):134-6. PubMed ID: 13447339
    [No Abstract]   [Full Text] [Related]  

  • 18. [Identification of Mycobacterium tuberculosis strains and a simultaneous identification of their drug resistance by the hybridization method on oligonucleotide microchips].
    Griadunov DA; Mikhaĭlovich VM; Lapa SA; Rudinskiĭ NI; Barskiĭ VE; Chudinov AV; Zasedatelev AS; Mirzabekov AD
    Mol Gen Mikrobiol Virusol; 2003; (4):24-7. PubMed ID: 14664159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple mutations in katG and inhA identified in Thai isoniazid-resistant Mycobacterium tuberculosis isolates.
    Khadka DK; Eampokalap B; Panitchakorn J; Ramasoota P; Khusmith S
    Southeast Asian J Trop Med Public Health; 2007 Mar; 38(2):376-82. PubMed ID: 17539290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of pyrazinamide and cycloserine on Mycobacterium tuberculosis in vitro in the presence of purulent exudata].
    CERCHIAI E
    G Ital Della Tuberc; 1958; 12(2):71-3. PubMed ID: 13548547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.